GE HealthCare Technologies Inc. GEHC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus · Nasdaq
Revenue
$19.55B
+6.6% YoY
Net income
$1.57B
-18.2% YoY
Total assets
$33.09B
+2.0% YoY
EPS
3.03
-28.2% YoY
Advertisement
Income Statement
| Period | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Revenues | $14.93B | $9.78B | $4.78B | $19.55B | $14.35B | $9.49B | $4.65B | $18.34B |
| Gross Profit | $5.99B | $4.00B | $2.01B | $7.92B | $5.93B | $3.90B | $1.90B | $7.18B |
| R&D Expense | $937.00M | $646.00M | $344.00M | $1.21B | $967.00M | $651.00M | $324.00M | $1.03B |
| SG&A Expense | $3.11B | $2.07B | $1.04B | $4.28B | $3.14B | $2.10B | $1.04B | $3.63B |
| Operating Income (Loss) | $1.94B | $1.28B | $629.00M | $2.44B | $1.82B | $1.15B | $540.00M | $2.52B |
| Net Income (Loss) | $1.50B | $1.05B | $564.00M | $1.57B | $1.27B | $802.00M | $374.00M | $1.92B |
| EPS (Diluted) | 3.26 | 2.29 | 1.23 | 3.03 | 2.77 | 1.75 | 0.81 | 4.22 |
Balance Sheet
| Period | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $36.91B | $36.91B | $36.91B | $33.09B | $33.09B | $33.09B | $33.09B | $32.45B |
| Current Assets | $12.50B | $12.50B | $12.50B | $9.90B | $9.90B | $9.90B | $9.90B | $9.41B |
| Cash & Equivalents | $4.49B | $4.49B | $4.49B | $2.87B | $2.87B | $2.87B | $2.87B | $2.49B |
| Inventory | $2.23B | $2.23B | $2.23B | $1.94B | $1.94B | $1.94B | $1.94B | $1.96B |
| PP&E (Net) | — | — | — | — | — | — | — | — |
| Goodwill | $13.49B | $13.49B | $13.49B | $12.94B | $13.14B | $13.14B | $13.14B | $12.81B |
| Total Liabilities | $26.31B | $26.31B | $26.31B | $24.44B | $24.44B | $24.44B | $24.44B | $25.14B |
| Current Liabilities | $9.11B | $9.11B | $9.11B | $9.55B | $9.55B | $9.55B | $9.55B | $8.98B |
| Accounts Payable | $3.25B | $3.25B | $3.25B | $3.04B | $3.04B | $3.04B | $3.04B | $2.95B |
| Long-Term Debt | $10.00B | $10.00B | $10.00B | $8.95B | $8.95B | $8.95B | $8.95B | $9.44B |
| Stockholders Equity | $10.38B | $10.38B | $10.38B | $8.45B | $8.45B | $8.45B | $8.45B | $7.13B |
Cash Flow Statement
| Period | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $937.00M | $344.00M | $250.00M | — | — | $300.00M | $419.00M | — |
| Investing Cash Flow | $-778.00M | $-630.00M | $-407.00M | $-558.00M | $-674.00M | $-537.00M | $-188.00M | $-398.00M |
| Financing Cash Flow | $910.00M | $1.07B | $-286.00M | $-478.00M | $704.00M | $-210.00M | $-153.00M | $-822.00M |
| Stock Repurchases | $200.00M | $100.00M | $0 | $0 | $0 | $0 | — | — |
Learn more
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
Data is sourced from the U.S. SEC EDGAR public database. This site does not provide investment advice.